{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T22:42:55Z","timestamp":1795128175661,"version":"4.10.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"DOI":"10.1186\/s13052-025-02156-8","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T15:22:31Z","timestamp":1765898551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Doxycycline vs levofloxacin for macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a real-world study from China"],"prefix":"10.1186","volume":"51","author":[{"given":"Ruling","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqiu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaihuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5457-4462","authenticated-orcid":false,"given":"Xiaoying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"2156_CR1","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3201\/eid2706.203206","volume-title":"Macrolide-resistant mycoplasma pneumoniae infections in children","author":"MM Lanata","year":"2021","unstructured":"Lanata MM, Wang H, Everhart K, Moore-Clingenpeel M, Ramilo O, Leber A. Macrolide-resistant Mycoplasma pneumoniae infections in children. Vol. 27. Ohio, USA: Emerg Infect Dis; 2021. p. 1588\u201397. https:\/\/doi.org\/10.3201\/eid2706.203206"},{"issue":"4","key":"2156_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/adc.83.4.347","volume":"83","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2000","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Lamireau T, Chawki D, Maleville J, Ta\u00efeb A. Diagnosis, classification, and management of erythema multiforme and stevens-johnson syndrome. Arch Dis Child. 2000;83(4):347\u201352. https:\/\/doi.org\/10.1136\/adc.83.4.347","journal-title":"Arch Dis Child"},{"issue":"2","key":"2156_CR3","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1016\/S2666-5247(23)00344-0","volume":"5","author":"PM Meyer Sauteur","year":"2024","unstructured":"Meyer Sauteur PM, Beeton ML, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe. 2024;5(2):e100\u20131. https:\/\/doi.org\/10.1016\/S2666-5247(23)00344-0","journal-title":"Lancet Microbe"},{"issue":"1","key":"2156_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12519-023-00783-x","volume":"20","author":"C Yan","year":"2024","unstructured":"Yan C, Xue GH, Zhao HQ, Feng YL, Cui JH, Yuan J. Current status of Mycoplasma pneumoniae infection in China. World J Pediatr. 2024;20(1):1\u20134. https:\/\/doi.org\/10.1007\/s12519-023-00783-x","journal-title":"World J Pediatr"},{"issue":"9","key":"2156_CR5","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s12519-024-00831-0","volume":"20","author":"YS Wang","year":"2024","unstructured":"Wang YS, Zhou YL, Bai GN, Li SX, Xu D, Chen LN, et al. Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. World J Pediatr. 2024;20(9):901\u201304. https:\/\/doi.org\/10.1007\/s12519-024-00831-0","journal-title":"World J Pediatr"},{"key":"2156_CR6","doi-asserted-by":"publisher","first-page":"1181402","DOI":"10.3389\/fcimb.2023.1181402","volume":"13","author":"TT Jiang","year":"2023","unstructured":"Jiang TT, Sun L, Wang TY, Qi H, Tang H, Wang YC, et al. The clinical significance of macrolide resistance in pediatric Mycoplasma pneumoniae infection during COVID-19 pandemic. Front Cell Infect Microbiol. 2023;13:1181402. https:\/\/doi.org\/10.3389\/fcimb.2023.1181402","journal-title":"Front Cell Infect Microbiol"},{"key":"2156_CR7","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/idr13030073","volume":"13","author":"D Loconsole","year":"2021","unstructured":"Loconsole D, De Robertis AL, Sallustio A, Centrone F, Morcavallo C, Campanella S, et al. Update on the epidemiology of macrolide-resistant Mycoplasma pneumoniae in Europe: a systematic review. Infect Dis Rep. 2021;13:811\u201320. https:\/\/doi.org\/10.3390\/idr13030073","journal-title":"Infect Dis Rep"},{"key":"2156_CR8","doi-asserted-by":"publisher","first-page":"e2220949","DOI":"10.1001\/jamanetworkopen.2022.20949","volume":"5","author":"K Kim","year":"2022","unstructured":"Kim K, Jung S, Kim M, Park S, Yang HJ, Lee E. Global trends in the proportion of macrolide-resistant mycoplasma pneumoniae infections: a systematic review and meta-analysis. JAMA Netw Open. 2022;5:e2220949. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.20949","journal-title":"JAMA Netw Open"},{"key":"2156_CR9","doi-asserted-by":"publisher","first-page":"1489389","DOI":"10.3389\/fped.2024.1489389","volume":"12","author":"Y Li","year":"2024","unstructured":"Li Y, Liu Y, Chen X, Xiao X, Chen Y, Wang L, et al. Clinical characteristics and predictive indictors of macrolide-unresponsive mycoplasma pneumoniae pneumonia in children: a retrospective study. Front Pediatr. 2024;12:1489389. https:\/\/doi.org\/10.3389\/fped.2024.1489389","journal-title":"Front Pediatr"},{"issue":"2","key":"2156_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3760\/cma.j.cn331340-20230217-00023","volume":"50","author":"National Health Commission of the People\u2019s Republic of China","year":"2023","unstructured":"National Health Commission of the People\u2019s Republic of China. Guidelines for the diagnosis and treatment of mycoplasma pneumoniae pneumonia in children (2023 edition). Int J Epidemiol And Infect Disease. 2023;50(2):79\u201385. https:\/\/doi.org\/10.3760\/cma.j.cn331340-20230217-00023","journal-title":"Int J Epidemiol And Infect Disease"},{"key":"2156_CR11","doi-asserted-by":"publisher","first-page":"6495","DOI":"10.2147\/JIR.S387809","volume":"15","author":"Q Xie","year":"2022","unstructured":"Xie Q, Zhang X, Cui W, Pang Y. Construction of a nomogram for identifying refractory mycoplasma pneumoniae pneumonia among macrolide-unresponsive mycoplasma pneumoniae pneumonia in children. J Inflamm Res. 2022;15:6495\u2013504. https:\/\/doi.org\/10.2147\/JIR.S387809","journal-title":"J Inflamm Res"},{"issue":"11","key":"2156_CR12","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.21037\/tp-21-356","volume":"10","author":"J Chen","year":"2021","unstructured":"Chen J, Qi X, Yin Y, Zhang L, Zhang J, Yuan S. Effects of minocycline on macrolide-unresponsive mycoplasma pneumoniae pneumonia in children: a singlecenter retrospective study. Transl Pediatr. 2021;10(11):2997\u20133004. https:\/\/doi.org\/10.21037\/tp-21-356","journal-title":"Transl Pediatr"},{"key":"2156_CR13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3389\/fmicb.2016.00693","volume":"7","author":"T Yamazaki","year":"2016","unstructured":"Yamazaki T, Kenri T. Epidemiology of M. pneumoniae infections in Japan and therapeutic strategies for macrolide-resistant mycoplasma pneumoniae. Front Microbiol. 2016;7:693. https:\/\/doi.org\/10.3389\/fmicb.2016.00693","journal-title":"Front Microbiol"},{"issue":"1","key":"2156_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13052-024-01615-y","volume":"50","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhang Y, Tang QN, Shi HB. Efficacy of doxycycline therapy for macrolide-resistant mycoplasma pneumoniae pneumonia in children at different periods. Ital J Pediatr. 2024;50(1):38. https:\/\/doi.org\/10.1186\/s13052-024-01615-y","journal-title":"Ital J Pediatr"},{"issue":"1","key":"2156_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12936-017-1797-9","volume":"16","author":"T Gaillard","year":"2017","unstructured":"Gaillard T, Briolant S, Madamet M, Pradines B. The end of a dogma: the safety of doxycycline use in young children for malaria treatment. Malar J. 2017;16(1):148. https:\/\/doi.org\/10.1186\/s12936-017-1797-9","journal-title":"Malar J"},{"issue":"9","key":"2156_CR16","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/jcph.715","volume":"56","author":"K Patel","year":"2016","unstructured":"Patel K, Goldman JL. Safety concerns surrounding quinolone use in children. J Clin Pharmacol. 2016;56(9):1060\u201375. https:\/\/doi.org\/10.1002\/jcph.715","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"2156_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/INF.0000000000001710","volume":"37","author":"JD Cherry","year":"2018","unstructured":"Cherry JD, Wendorf K, Bregman B, Lehman D, Nieves D, Bradley JS, Mason WH, Sande-Lopez L, Lopez M, Federman M, Chen T, Blumberg D, Johnston S, Schwenk HT, Weintrub P, Quinn KK, Winter K, Harriman K. An observational study of severe pertussis in 100 infants \u2264120 days of age. Pediatr Infect Dis J. 2018, Mar;37(3):202\u201305. https:\/\/doi.org\/10.1097\/INF.0000000000001710","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"2156_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12879-024-10370-8","volume":"25","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Su C, Zhang Y, Ding S, Yan X, Zhang J, et al. Epidemiological and clinical characteristics of hospitalized pediatric patients with mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter study. BMC Infect Dis. 2025;25(1):18. https:\/\/doi.org\/10.1186\/s12879-024-10370-8","journal-title":"BMC Infect Dis"},{"key":"2156_CR19","doi-asserted-by":"publisher","first-page":"9227838","DOI":"10.1155\/2022\/9227838","volume":"2022","author":"W Huang","year":"2022","unstructured":"Huang W, Xu X, Zhao W, Cheng Q. Refractory mycoplasma pneumonia in children: a systematic review and meta-analysis of laboratory features and predictors. J Immunol Res. 2022;2022:9227838. https:\/\/doi.org\/10.1155\/2022\/9227838","journal-title":"J Immunol Res"},{"key":"2156_CR20","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.2147\/IDR.S466994","volume":"17","author":"J Cheng","year":"2024","unstructured":"Cheng J, Liu Y, Zhang G, Tan L, Luo Z. Azithromycin effectiveness in children with mutated mycoplasma pneumoniae pneumonia. Infect Drug Resist. 2024;17:2933\u201342. https:\/\/doi.org\/10.2147\/IDR.S466994","journal-title":"Infect Drug Resist"},{"key":"2156_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13756-019-0576-5","volume":"8","author":"F Zhao","year":"2019","unstructured":"Zhao F, Li J, Liu J, Guan X, Gong J, Liu L, et al. Antimicrobial susceptibility and molecular characteristics of mycoplasma pneumoniae isolates across different regions of China. Antimicrob Resist Infect Control. 2019;8:143. https:\/\/doi.org\/10.1186\/s13756-019-0576-5","journal-title":"Antimicrob Resist Infect Control"},{"issue":"6","key":"2156_CR22","doi-asserted-by":"publisher","first-page":"300060521101637","DOI":"10.1177\/03000605211016376","volume":"49","author":"C Xu","year":"2021","unstructured":"Xu C, Deng H, Zhang J, Zhu Y, Rong Q, Quan Y, et al. Mutations in domain V of mycoplasma pneumoniae 23S rRNA and clinical characteristics of pediatric M. pneumoniae pneumonia in Nanjing, China. J Int Med Res. 2021;49(6):3000605211016376. https:\/\/doi.org\/10.1177\/03000605211016376","journal-title":"J Int Med Res"},{"issue":"4","key":"2156_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jmii.2020.10.002","volume":"54","author":"TA Tsai","year":"2021","unstructured":"Tsai TA, Tsai CK, Kuo KC, Yu HR. Rational stepwise approach for mycoplasma pneumoniae pneumonia in children. J Microbiol Immunol Infect. 2021;54(4):557\u201365. https:\/\/doi.org\/10.1016\/j.jmii.2020.10.002","journal-title":"J Microbiol Immunol Infect"},{"key":"2156_CR24","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","volume":"7","author":"S Pereyre","year":"2016","unstructured":"Pereyre S, Goret J, B\u00e9b\u00e9ar C. Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment. Front Microbiol. 2016;7:974. https:\/\/doi.org\/10.3389\/fmicb.2016.00974","journal-title":"Front Microbiol"},{"key":"2156_CR25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1128\/AAC.50.2.709-712.2006","volume":"50","author":"S Suzuki","year":"2006","unstructured":"Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, et al. Clinical evaluation of macrolide-resistant mycoplasma pneumoniae. Antimicrob Agents Chemother. 2006;50:709\u201312. https:\/\/doi.org\/10.1128\/AAC.50.2.709-712.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2156_CR26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s10156-009-0715-7","volume":"15","author":"K Matsubara","year":"2009","unstructured":"Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother. 2009;15:380\u201383. https:\/\/doi.org\/10.1007\/s10156-009-0715-7","journal-title":"J Infect Chemother"},{"key":"2156_CR27","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1128\/JCM.02840-12","volume":"51","author":"F Cardinale","year":"2013","unstructured":"Cardinale F, Chironna M, Chinellato I, Principi N, Esposito S. Clinical relevance of mycoplasma pneumoniae macrolide resistance in children. J Clin Microbiol. 2013;51:723\u201324. https:\/\/doi.org\/10.1128\/JCM.02840-12","journal-title":"J Clin Microbiol"},{"issue":"7","key":"2156_CR28","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3201\/eid2607.200017","volume":"26","author":"YC Chen","year":"2020","unstructured":"Chen YC, Hsu WY, Chang TH. Macrolide-resistant mycoplasma pneumoniae infections in pediatric community-acquired pneumonia. Emerg. Infect. Dis. 2020, Jul;26(7):1382\u201391. https:\/\/doi.org\/10.3201\/eid2607.200017","journal-title":"Emerg. Infect. Dis"},{"issue":"1","key":"2156_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40262-021-01061-7","volume":"61","author":"EN Drwiega","year":"2022","unstructured":"Drwiega EN, Rodvold KA. Penetration of antibacterial agents into pulmonary epithelial lining fluid: an update. Clin Pharmacokinet. 2022, Jan;61(1):17\u201346. https:\/\/doi.org\/10.1007\/s40262-021-01061-7.","journal-title":"Clin Pharmacokinet"},{"issue":"43","key":"2156_CR30","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.3346\/jkms.2018.33.e268","volume":"33","author":"SG Ha","year":"2018","unstructured":"Ha SG, Oh KJ, Ko KP, Sun YH, Ryoo E, Tchah H, et al. Therapeutic efficacy and safety of prolonged macrolide, corticosteroid, doxycycline, and Levofloxacin against macrolide-unresponsive mycoplasma pneumoniae pneumonia in children. J Korean Med Sci. 2018;33(43):e268. https:\/\/doi.org\/10.3346\/jkms.2018.33.e268","journal-title":"J Korean Med Sci"},{"issue":"12","key":"2156_CR31","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.7499\/j.issn.1008-8830.2406089","volume":"26","author":"YC Ma","year":"2024","unstructured":"Ma YC, Zhou XH, Zhao XD, Wang CY. Efficacy of prolonged azithromycin versus switching to doxycycline in the treatment of macrolide-unresponsive mycoplasma pneumoniae pneumonia in children. Zhongguo Dang Dai Er Ke Za Zhi. 2024;26(12):1294\u2013300. https:\/\/doi.org\/10.7499\/j.issn.1008-8830.2406089","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"2156_CR32","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.2147\/IDR.S370126","volume":"15","author":"N Wang","year":"2022","unstructured":"Wang N, Zhang H, Yin Y, Xu X, Xiao L, Liu Y. Antimicrobial susceptibility profiles and genetic characteristics of mycoplasma pneumoniae in Shanghai, China, from 2017 to 2019. Infect Drug Resist. 2022;15:4443\u201352. https:\/\/doi.org\/10.2147\/IDR.S370126","journal-title":"Infect Drug Resist"},{"issue":"12","key":"2156_CR33","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.3390\/microorganisms10122428","volume":"10","author":"T Oishi","year":"2022","unstructured":"Oishi T, Yoshioka D, Nakano T, Ouchi K. Recent trend of antimicrobial susceptibility among mycoplasma pneumoniae isolated from Japanese children. Microorganisms. 2022;10(12):2428. https:\/\/doi.org\/10.3390\/microorganisms10122428","journal-title":"Microorganisms"},{"issue":"2","key":"2156_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.sdentj.2014.02.002","volume":"26","author":"MQ Alqahtani","year":"2014","unstructured":"Alqahtani MQ. Tooth-bleaching procedures and their controversial effects: a literature review. Saudi Dent J. 2014, Apr;26(2):33\u201346. https:\/\/doi.org\/10.1016\/j.sdentj.2014.02.002.","journal-title":"Saudi Dent J"},{"issue":"3","key":"2156_CR35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1517\/14740338.2016.1133584","volume":"15","author":"R Cross","year":"2016","unstructured":"Cross R, Ling C, Day NP, McGready R, Paris DH. Revisiting doxycycline in pregnancy and early childhood\u2013time to rebuild its reputation? Expert Opin Drug Saf. 2016;15(3):367\u201382. https:\/\/doi.org\/10.1517\/14740338.2016.1133584","journal-title":"Expert Opin Drug Saf"},{"issue":"RR-4","key":"2156_CR36","first-page":"1","volume":"55","author":"AS Chapman","year":"2006","unstructured":"Chapman AS, Bakken JS, Folk SM, Paddock CD, Bloch KC, Krusell A, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis\u2013United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep. 2006;55(RR-4):1\u201327","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"2156_CR37","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1186\/s12879-021-06508-7","volume":"21","author":"JG Ahn","year":"2021","unstructured":"Ahn JG, Cho HK, Li D, Choi M, Lee J, Eun BW, et al. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):1003. https:\/\/doi.org\/10.1186\/s12879-021-06508-7","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2156_CR38","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1542\/peds.2013-3636","volume":"134","author":"JS Bradley","year":"2014","unstructured":"Bradley JS, Kauffman RE, Balis DA, Duffy CM, Gerbino PG, Maldonado SD, et al. Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin. Pediatrics. 2014;134(1):e146\u201353. https:\/\/doi.org\/10.1542\/peds.2013-3636","journal-title":"Pediatrics"},{"issue":"5","key":"2156_CR39","doi-asserted-by":"publisher","first-page":"e20162706","DOI":"10.1542\/peds.2016-2706","volume":"138","author":"MA Jackson","year":"2016","unstructured":"Jackson MA, Schutze GE. Committee on infectious diseases. The use of systemic and topical fluoroquinolones. Pediatrics. 2016;138(5):e20162706. https:\/\/doi.org\/10.1542\/peds.2016-2706","journal-title":"Pediatrics"},{"issue":"6","key":"2156_CR40","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/bjd\/ljae099","volume":"190","author":"CJ Thang","year":"2024","unstructured":"Thang CJ, Garate D, O\u2019Leary S, Golovko G, Wilkerson MG, Barbieri JS. Evaluation of the association between tetracycline-class antibiotic use in patients with acne and idiopathic intracranial hypertension risk: a population-level cohort study. Br J Dermatol. 2024, May, 17;190(6):921\u201323. https:\/\/doi.org\/10.1093\/bjd\/ljae099","journal-title":"Br J Dermatol"},{"key":"2156_CR41","doi-asserted-by":"publisher","first-page":"117954411983522","DOI":"10.1177\/1179544119835222","volume":"12","author":"ME Fern\u00e1ndez-Cuadros","year":"2019","unstructured":"Fern\u00e1ndez-Cuadros ME, Casique-Bocanegra LO, Albaladejo-Flor\u00edn MJ, G\u00f3mez-Due\u00f1as S, Ramos-Gonzalez C, P\u00e9rez-Moro OS. Bilateral levofloxacin-induced achilles tendon rupture: an uncommon case report and review of the literature. Clin Med Insights Arthritis Musculoskelet Disord. 2019, Mar, 5;12:1179544119835222. https:\/\/doi.org\/10.1177\/1179544119835222","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02156-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-02156-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02156-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T03:02:10Z","timestamp":1765940530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13052-025-02156-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2156"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-02156-8","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This real-word study used data from routine clinical examinations, with personal identifiable information removed. As the study did not involve additional interventions or experimental operations, the ethics committee approved the waiver of informed consent. The study was approved by the Ethics Committee of the Children\u2019s Hospital of Chongqing Medical University (Approval No. 2024-Research-247), on June 27, 2024, and complies with the ethical standards of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"320"}}